April 18, 2014

DIVISION OF MINIMALLY INVASIVE UROLOGIC SURGERY


OUR SURGEONS

   JOHNS HOPKINS HOSPITAL

    Mohamad E. Allaf, MD
    Trinity J. Bivalacqua, M.D, Ph.D
    Misop Han, M.D.
    Brian R. Matlaga, M.D., M.P.H.
    Alan W. Partin, M.D., Ph.D.
   Ashley E. Ross, M.D., Ph.D.
   Phillip M. Pierorazio, M.D.
    Edward Schaeffer, M.D., Ph.D.

  JOHNS HOPKINS BAYVIEW
  MEDICAL CENTER

   Brian R. Matlaga, M.D., M.P.H.
   Christian Pavlovich, M.D.


PROCEDURES
FOR PROSTATE CANCER
FOR KIDNEY CANCER
FOR KIDNEY STONES
FOR KIDNEYS DONATION
FOR KIDNEY BLOCKAGE
    OR KIDNEY CYSTS
FOR TESTIS CANCER
FOR PELVIC PROLAPSE
FOR ADRENAL TUMORS

RESOURCES

   VIDEO
   For Prostate Cancer
   For Kidney Cancer
   Kidneys Stones
   Kidney Donation
   Pelvic Prolapse


   PUBLICATIONS

   DRIVING DIRECTIONS


APPOINTMENTS

   JOHNS HOPKINS HOSPITAL
  
  Mohamad E. Allaf, M.D.
   Trinity J. Bivalacqua, M.D, Ph.D
  Misop Han, M.D.
  • Brian R. Matlaga, M.D., M.P.H.
  • Alan W. Partin, M.D., Ph.D.
  • Edward Schaeffer, M.D., Ph.D.
     410-955-6100

  JOHNS HOPKINS BAYVIEW
  MEDICAL CENTER

   Christian Pavlovich, M.D.
    410-550-0013
  Brian R. Matlaga, M.D., M.P.H.
     410-955-6100

 

 

  DIVISION SURGEONS

mohamad allaf

     Office: 410-502-7710
     Appointments: 410-955-6100
     Fax: 410-502-7711
     Email: mallaf@jhmi.edu

Mohamad E. Allaf, MD

      Dr. Allaf is an Assistant Professor of Urology and Biomedical Engineering at the Brady Urological Institute and Director of Minimally Invasive and Robotic Surgery at the Johns Hopkins Hospital. He joined the staff after receiving his undergraduate and medical degrees from the Johns Hopkins University and completing his residency and advanced training in Urology at Johns Hopkins as well.
     His main clinical interest includes the treatment of kidney tumors and prostate cancer in the least morbid way possible. He specializes in the management of kidney tumors via laparoscopic (total and partial kidney removal) and percutaneous (non-surgical) approaches. He also has an interest in the careful and active observation of select small kidney tumors. His other areas of focus include performing nerve sparing radical prostatectomy in all its forms (open, laparoscopic, and robotic) as well as reconstructive laparoscopy (pyeloplasty) and laparoscopic management of testicular cancer (retroperitoneal lymph node dissection).
     His research endeavors involve investigating approaches to minimize the morbidity of urologic surgery and the development of ways to decrease injury to the neurovascular bundles and hasten erection recovery following radical prostatectomy. Dr. Allaf has been the recipient of numerous academic awards, including placing first in the 2005 American Urological Association clinical and laboratory research annual essay contests. He has written and published numerous research articles, textbook chapters, patents and video presentations in the field of Laparoscopic and Robotic Urologic Surgery.

trinity bivalacqua

    
  Office: 443-287-0385
  Appointments:410-955-6100
  Fax:410-614-3695
  Email: tbivala1@jhmi.edu

Trinity J. Bivalacqua, M.D, Ph.D

Trinity J. Bivalacqua, M.D., Ph.D., Assistant Professor of Urology and Oncology, was born in New Orleans, Louisiana and graduated from Tulane University with undergraduate, graduate and medical degrees. He joined the faculty after completing his General Surgery and Urology training at Johns Hopkins Hospital. He also received an American Urological Association (AUA) Foundation Fellowship for his pioneering work on neuroregulatory control of penile erection.

Dr. Bivalacqua has an active clinical practice in Urologic Oncology, Andrology and Benign Prostatic disease.  His specific interest is in Prostate, Bladder and Penile cancers, Erectile Dysfunction, Peyronie’s Disease, Priapism.  He has expertise in open, laparoscopic and robot treatment of these genitourinary malignancies.

Dr. Bivalacqua has received national and international recognition for his research involving the pathophysiology and novel treatment strategies for Erectile Dysfunction and Priapism.  His laboratory currently investigates novel molecular pathways that are involved in post-radical prostatectomy erectile dysfunction, diabetes-induced erectile dysfunction, and sickle cell disease-associated priapism. He was the first person to describe the use of gene therapy targeting the endothelium of the penis for the treatment of erectile dysfunction.  Through his scientific discoveries, new pharmacological and gene therapies have been developed for male erectile dysfunction.




     Office: 410-502-7454  
     Appointments:410-955-6100
     Fax:410 502-7711
     Email: mhan1@jhmi.edu

Misop Han, M.D.

     Dr. Misop Han is an Associate Professor of Urology at the Brady Urological Institute at The Johns Hopkins Hospital. He received his undergraduate, medical school and urology training at Johns Hopkins. After his training, he worked as an Assistant Professor of Urology at the Feinberg School of Medicine at Northwestern University and as a urologist at Northwestern Memorial Hospital in Chicago, Illinois. Dr. Han was head of Northwestern University's clinical database for prostate cancer research. In 2006, he was recruited back to join the faculty at the Brady Urological Institute at Johns Hopkins Hospital.
    Dr. Han is a board-certified urologist whose main clinical focus is in urological oncology with a special emphasis on prostate and kidney cancers. He specializes in nerve-sparing radical retropubic prostatectomy, robotic-assisted laparoscopic radical prostatectomy and laparoscopic nephrectomy.
     Dr. Han has received recognition for his research involving the outcome of surgery for prostate cancer and has received national awards for his research. His research interests include the outcome of radical prostatectomy and prediction modeling (what happens to men following surgery for prostate cancer). He has published extensively in these subjects(click here for details). He is actively involved in several clinical research projects with the database of more than 14,000 men who received surgery for prostate cancer at The Johns Hopkins Hospital.




matlaga

          
  Office: 410 502-7710
  Appointments:410 955-6100
  Fax:410 502-7711
  Email: bmatlag1@jhmi.edu

Brian R. Matlaga, M.D., M.P.H.

      Dr. Brian Matlaga is Associate Professor of Urology at The Brady Urological Institute and the Director of Stone Disease at Johns Hopkins Bayview Medical Center. Dr. Matlaga came to Johns Hopkins after completing a fellowship in minimally invasive surgery and metabolic stone disease. During his fellowship he was designated an American Foundation for Urologic Disease Research Scholar, and was awarded the Outstanding Research Scholar honor in recognition of his work involving the treatment of patients with stone disease.
      Dr. Matlaga’s main clinical interest is the minimally invasive treatment of patients with metabolic stone disease, including percutaneous nephrolithotomy, ureteroscopy, and shock wave lithotripsy. In addition, Dr. Matlaga has an interest in the holmium laser enucleation of the prostate (HoLEP), a minimally invasive laser therapy for men with benign prostatic enlargement.
      As the Director of Stone Disease, Dr. Matlaga is actively engaged in clinical and basic science research addressing the questions of: Which patients develop stones? How do stones form? How well are we treating patients with stones?


Alan Partin

  Appointments:
410-614-4876
  Fax:410-955-0833
  Email: apartin@jhmi.edu

Alan W. Partin, M.D., Ph.D.

Alan W.Partin M.D., Ph.D., Professor of Urology the Johns Hopkins Medical Institution, has both basic science and clinical interest in prognosis prediction for men with prostate cancer. Dr. Partin's laboratories and clinical and surgical interest are focused on development and testing of new and existing methods for predicting the aggressiveness of prostate cancers so that rational treatment decisions can be made by both patients and physicians. Dr. Partin's laboratories have investigated many new serum tests, some of which are soon to become available for the diagnosis of prostate cancer as well as basics science investigation of new proteins, which may help in detection, and staging of prostate cancer. In addition, Dr. Partin has an academic and clinical interest in treatment of benign prostatic hyperplasia with an emphasis on minimally invasive techniques for treatment of this common disease of men.




christian pavlovich

  Office: 410 550-0013
  Appointments:
410-550-7008
  Fax:(410) 550-4188
  Email: cpavlov2@jhmi.edu

Christian Pavlovich, M.D

Christian Pavlovich, M.D. is Director of Urologic Oncology at the Johns Hopkins Bayview Medical Center. He came to Johns Hopkins after completing a urologic oncology fellowship at the National Cancer Institute in Bethesda, Maryland.

Currently, he applies his expertise in open, laparoscopic, and other minimally invasive techniques primarily to patients with urologic cancers. His main current focus is the treatment of prostate, bladder, and kidney cancers with minimal morbidity and maximal oncologic efficacy. To this effect, he has developed a busy cancer practice, where he offers nerve-sparing laparoscopic, robot-assisted laparoscopic, and open radical prostatectomy for prostate cancer, laparoscopic radical cystectomy for bladder cancer, and open and laparoscopic approaches to the kidney for kidney cancer.




Phillip M. Pierorazio

  Office: 410 502 5984
  Appointments:
410 955 6100
  Fax:410 502 7711
  Email: philpierorazio@jhmi.edu

Phillip M. Pierorazio, M.D.

Dr. Phillip Pierorazio, originally from New York, received his undergraduate degree from Georgetown University in Washington, DC and his medical degree from Columbia University, College of Physicians & Surgeons in New York City. Prior to starting residency, he was accepted and spent a year as a Doris Duke Clinical Research Fellow in Urologic Oncology. After completing residency and advanced training at the Johns Hopkins Hospital, he joined the staff of the James Buchanan Brady Urological Institute, Department of Urology and Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins as an Assistant Professor of Urology and Oncology.

Dr. Pierorazio has expertise in all malignancies of the urinary tract, including kidney, bladder, prostate, testis, adrenal, penile and urethral cancer. He performs both open and minimally-invasive surgeries including laparoscopic and robotic surgeries of the kidney, bladder and prostate. He has a special interest in kidney cancer, including partial nephrectomy for early stage disease and high-risk surgeries for patients with advanced urological cancers.




Ashley E. Ross, MD, PhD

  Office: (443) 287-7225
  Appointments:

  Fax:(410)-614-8096
  Email: aross2@jhmi.edu

Ashley E. Ross, M.D., Ph.D.

Ashley E. Ross, MD, PhD, Assistant professor of Urology, Oncology and Pathology, was born in Buffalo New York and graduated from The Johns Hopkins School of Medicine with graduate and medical degrees. He joined the faculty after completing his general surgery and urology training at Johns Hopkins.

Dr. Ross has an active clinical practice which focuses on Prostate Cancer and Prostatic Diseases such as Benign Prostatic Hyperplasia. He has expertise in open and robotic treatment of prostate cancer as well as in focal and salvage prostate cryotherapy and in the active surveillance of prostate cancer. He additionally has expertise in the treatment of benign prostatic hyperplasia through the use of transurethral resection, laser photo-vaporization and through open surgical approaches. As an active member of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Dr. Ross participates in multi-disciplinary approaches to the treatment of prostate cancer.



     Appointments:410-502-3143
     Email: eschaef4@jhmi.edu

Edward M. Schaeffer, M.D., Ph.D.

     Edward M (Ted) Schaeffer, MD, PhD, Assistant Professor of Urology, Oncology and Pathology, was born in Palo Alto California and graduated from University of Chicago with undergraduate, graduate and medical degrees. He joined the faculty after completing his general surgery and urology training at Johns Hopkins.
    Dr. Schaeffer has an active clinical practice in Urologic Oncology specializing in Prostate, Bladder and Kidney cancer. He has expertise in open, laparoscopic and robot treatment of these malignancies. As an active member of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Dr Schaeffer participates in multidisciplinary approaches to the treatment of genitourinary cancers.
    Dr Schaeffer is also a fully trained scientist and an expert in prostate development and prostate carcinogenesis. His laboratory currently investigates novel pathways of prostate and bladder carcinogenesis through utilization of experimental embryology and systems of epithelial injury repair.



  PROCEDURES

For Prostate Cancer:

Nerve-Sparing Robotic Radical Prostatectomy a minimally invasive surgical technique to remove the prostate gland in patients diagnosed with prostate cancer using robotic assisted surgery.

Perineal Prostatectomy a minimally invasive surgical technique to remove the prostate gland through an incision made in the perineum.


For Kidney Cancer:

Laparoscopic Radical Nephrectomy: a minimally invasive surgical technique to remove a diseased kidney (e.g. from cancer, blockage, or stone disease).

Laparoscopic Partial Nephrectomy: a minimally invasive surgical technique to remove a small renal tumor, while preserving the remainder of the kidney.

Percutaneous Ablation Of Renal Tumors a minimally invasive surgical technique of renal tumor ablation using a needle placed through the skin


For Kidney Stones:

Extracorporeal shock wave lithotripsy (ESWL) a non invasive technique that uses sound waves (also called shock waves) to break a kidney stone into small pieces

Ureteroscopy: is a procedure using a thin telescope (ureteroscope), which is passed through the urethra (channel through which urine flows out of the bladder) used to treat stones within kidney or ureter.

Percutaneous Nephrolithotomy (PCNL): a minimally invasive technique for removing large kidney stones through a small incision made in the skin.



For Kidney Donation:

Laparoscopic Live Donor Nephrectomy: is a minimally invasive technique of kidney donation, which provides the least amount of discomfort for the donor while maintaining the health and quality of the kidney for transplantation.


For Kidney Blockage or Kidney Cysts:

Laparoscopic Pyeloplasty: a minimally invasive surgical technique used to reconstruct the drainage system of the kidney in patients suffering from blockage of a kidney at the ureteropelvic junction (i.e. the connection between the ureter or drainage tube and the kidney).

Laparoscopic Renal Cyst Ablation a minimally invasive surgical technique to excise symptomatic kidney cyst.


For Testis Cancer:

Laparoscopic Retroperitoneal Lymph Node Dissection (RPLND) a minimally invasive surgical technique to remove retroperitoneal lymph nodes in patients with testicular cancer.


For Pelvic Prolapse:

Laparoscopic Pelvic Organ Prolapse Repair (COLPOSUSPENSION) a minimally invasive surgical technique for resuspension of the vagina, bladder, and rectum in women with prolapse.



For Adrenal Tumors:

Laparoscopic Adrenalectomy a minimally invasive surgical technique for removing a diseased or cancerous adrenal gland.

  AUDIO-VIDEO RESOURCES

Warning: these video clips include footage from an actual surgery which some viewers may find difficult to watch.

Nerve-Sparing Robotic Radical Prostatectomy

Nerve-Sparing Laparoscopic Radical Prostatectomy

Laparoscopic Nephrectomy

Laparoscopic Live Donor Nephrectomy

Laparoscopic Live Donor Nephrectomy

Percutaneous Nephrolithotomy (PCNL)

Ureteroscopy

Laparoscopic Pelvic Organ Prolapse Repair (COLPOSUSPENSION)

Laparoscopic Pelvic Organ Prolapse Repair(COLPOSUSPENSION)

 

   PUBLICATIONS

 

  1. Laparoscopic Pyeloplasty: The First One Hundred Cases

  2. Laparoscopic Radical Nephrectomy : Cancer Control in Renal Cell Carcinoma

  3. Laparoscopic Live Donor Nephrectomy

  4. Use of a validated quality of life questionnaire to assess sexual function following laparoscopic radical prostatectomy.

  5. Classification and trends of perioperative morbidities following laparoscopic radical prostatectomy

  6. Health related quality of life before and after laparoscopic radical prostatectomy

  7. Nerve-sparing laparoscopic radical prostatectomy: replicating the open surgical technique.

  8. Making ends meet: a cost comparison of laparoscopic and open radical retropubic prostatectomy.

  9. Prospective comparison of short-term convalescence: laparoscopic radical prostatectomy versus open radical retropubic prostatectomy.

  10. CT Guided Percutaneous Renal Cryoablation of Renal Tumors

  11. Treatment of renal tumors with radiofrequency ablation

  12. Percutaneous radio frequency ablation of renal masses: results at a 2-year mean followup

  13. Trends in Complications following Laparoscopic Live Donor Nephrectomy



 

© Copyright 2014 | All Rights Reserved | Disclaimer
Email: webmaster@urology.jhu.edu | 600 North Wolfe Street, Baltimore, Maryland 21287